Pancreatic Cancer Research

ResearcherUniversity of Occupational and Environmental Health JapanNo recent work listed

Atsuhiro Koga

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5033582027. Sources: OpenAlex.

Their work

Papers
13
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2015: 1 paper · 2016: 5 papers · 2017: 2 papers · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 2 papers · 2022: 1 paper

Papers 13

  1. Concurrent Overexpression of Two Hyaluronidases, KIAA1199 and TMEM2, Strongly Predicts Shorter Survival After Resection in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000002106↗
  2. Hypoxia increases KIAA1199/CEMIP expression and enhances cell migration in pancreatic cancer. Co-author DOI 10.1038/s41598-021-97752-z↗
  3. Hypoxia Increases KIAA1199/CEMIP Expression and Enhances Cell Migration in Pancreatic Cancer Co-author DOI 10.21203/rs.3.rs-219524/v1↗
  4. Overexpression of transmembrane protein 2 (TMEM2), a novel hyaluronidase, predicts poor prognosis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2020.08.026↗
  5. 4-Methylumbelliferone inhibits enhanced hyaluronan synthesis and cell migration in pancreatic cancer cells in response to tumor-stromal interactions. Co-author DOI 10.3892/ol.2018.8147↗
  6. KIAA1199/CEMIP/HYBID overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2016.12.007↗
  7. KIAA1199 is induced by inflammation and enhances malignant phenotype in pancreatic cancer. Co-author DOI 10.18632/oncotarget.15052↗
  8. A novel epigenetic mechanism regulating hyaluronan production in pancreatic cancer cells. Co-author DOI 10.1007/s10585-015-9771-9↗
  9. Targeting hyaluronan for the treatment of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.apsb.2016.01.002↗
  10. Increased Expression of HYAL1 in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000000670↗
  11. Hyaluromycin, a Novel Hyaluronidase Inhibitor, Attenuates Pancreatic Cancer Cell Migration and Proliferation. Co-author DOI 10.1155/2016/9063087↗
  12. Hyaluronan stimulates pancreatic cancer cell motility. Co-author DOI 10.18632/oncotarget.6617↗
  13. Receptor for Hyaluronic Acid-Mediated Motility is Associated with Poor Survival in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.7150/jca.12990↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shiro Kohi · 13 shared papers, 2015–2022 · strength 1.25
  2. Keiji Hirata · 13 shared papers, 2015–2022 · strength 1.25
  3. Norihiro Sato · 13 shared papers, 2015–2022 · strength 1.25
  4. Xiaobo Cheng · 7 shared papers, 2015–2018 · strength 0.55
  5. Yuzan Kudo · 4 shared papers, 2020–2022 · strength 0.54
  6. Yasuhiro Adachi · 4 shared papers, 2020–2022 · strength 0.54
  7. Takuya Oba · 3 shared papers, 2021–2022 · strength 0.43
  8. Toshiyuki Nakayama · 2 shared papers, 2020–2022 · strength 0.26
  9. Masanori Hisaoka · 1 shared paper, 2017 · strength 0.08
  10. Yasuhiro Igarashi · 1 shared paper, 2016 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.